Cargando…

Retracted: Screening of Prospective Plant Compounds as H1R and CL1R Inhibitors and Its Antiallergic Efficacy through Molecular Docking Approach

Detalles Bibliográficos
Autor principal: Methods in Medicine, Computational and Mathematical
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356469/
https://www.ncbi.nlm.nih.gov/pubmed/37475919
http://dx.doi.org/10.1155/2023/9832631
_version_ 1785075282431967232
author Methods in Medicine, Computational and Mathematical
author_facet Methods in Medicine, Computational and Mathematical
author_sort Methods in Medicine, Computational and Mathematical
collection PubMed
description
format Online
Article
Text
id pubmed-10356469
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-103564692023-07-20 Retracted: Screening of Prospective Plant Compounds as H1R and CL1R Inhibitors and Its Antiallergic Efficacy through Molecular Docking Approach Methods in Medicine, Computational and Mathematical Comput Math Methods Med Retraction Hindawi 2023-07-12 /pmc/articles/PMC10356469/ /pubmed/37475919 http://dx.doi.org/10.1155/2023/9832631 Text en Copyright © 2023 Computational and Mathematical Methods in Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Methods in Medicine, Computational and Mathematical
Retracted: Screening of Prospective Plant Compounds as H1R and CL1R Inhibitors and Its Antiallergic Efficacy through Molecular Docking Approach
title Retracted: Screening of Prospective Plant Compounds as H1R and CL1R Inhibitors and Its Antiallergic Efficacy through Molecular Docking Approach
title_full Retracted: Screening of Prospective Plant Compounds as H1R and CL1R Inhibitors and Its Antiallergic Efficacy through Molecular Docking Approach
title_fullStr Retracted: Screening of Prospective Plant Compounds as H1R and CL1R Inhibitors and Its Antiallergic Efficacy through Molecular Docking Approach
title_full_unstemmed Retracted: Screening of Prospective Plant Compounds as H1R and CL1R Inhibitors and Its Antiallergic Efficacy through Molecular Docking Approach
title_short Retracted: Screening of Prospective Plant Compounds as H1R and CL1R Inhibitors and Its Antiallergic Efficacy through Molecular Docking Approach
title_sort retracted: screening of prospective plant compounds as h1r and cl1r inhibitors and its antiallergic efficacy through molecular docking approach
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356469/
https://www.ncbi.nlm.nih.gov/pubmed/37475919
http://dx.doi.org/10.1155/2023/9832631
work_keys_str_mv AT methodsinmedicinecomputationalandmathematical retractedscreeningofprospectiveplantcompoundsash1randcl1rinhibitorsanditsantiallergicefficacythroughmoleculardockingapproach